W. David Colby IV, MSc, MD, FRCPC - Infectious Disease: Travel Medicine and Tropical Diseases

Dr. W. David Colby IV reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. He is a well-known researcher who has been the principal or secondary investigator of several clinical trials. He was the regional coordinator for a nationally organized surveillance project. He also has been involved in many research groups, including the Vaccine and Virus Host Interactions Group (VVHIG), the Barer/Stoddart Report Task Force, and the Canadian ciprofloxacin study group. Dr. Colby is a consultant for the Infectious Diseases Service at London Health Sciences Centre. He also is the director of the University Hospital Travel Medicine and Tropical Diseases Service in London, Ontario.

Education and Training

MD: University of Toronto, Toronto, ON, 1984

Internship: Rotating, St. Joseph's Hospital, London, ON, 1984-1985

Fellowship in Cancer Research: University of Western Ontario, Department of Pathology, London, ON, 1985-1986

Residency in Medical Microbiology: University Hospital, London, ON, 1986-1989


Royal College of Physicians and Surgeons of Canada

Academic Appointments

University of Western Ontario, London, ON:

  • Associate Professor, Department of Microbiology and Immunology, 2001-present
  • Associate Professor, Department of Medicine, 2001-present
  • Assistant Professor, School of Dentistry, 1999-present
  • Assistant Professor, Department of Microbiology and Immunology, 1991-2001
  • Assistant Professor, Department of Medicine, 1991
  • Lecturer, Department of Medicine, 1990-1991
  • Lecturer (Honourary), Department of Microbiology and Immunology, 1989-1991
  • Honourary Lecturer, Department of Microbiology and Immunology, 1989

Fellowship Level Examiner, Canadian Society of Laboratory Technologists, 1990-present

Financial Disclosure

The final approval of Healthwise content is always made by a clinician with no financial conflicts.

This reviewer reported no financial conflicts.

Current as of: August 23, 2013